Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: results of a 12-week, prospective, open-label, pilot (METALL) study

Author(s): Gaydukova IZ, Rebrov AP, Poddubnyi DA

Abstract

inEnglish, Russian

Referred From: https://pubmed.ncbi.nlm.nih.gov/26155618/

Similar Articles

Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study

Author(s): Iglehart IW 3rd, Sutton JD, Bender JC, Shaw RA, Ziminski CM, et al.

Pulse methylprednisolone in SLE

Author(s): Kimberly RP

Intravenous methylprednisolone pulse therapy in ankylosing spondylitis

Author(s): Ejstrup L, Peters ND

Intravenous Methylprednisolone Pulse Therapy in Ankylosing Spondylitis

Author(s): Peters ND, Ejstrup L

A new strategy of drug treatment in NSAID-unreponsiveankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate

Author(s): Malaviya AN, Kapoor S, Garg S, Ahmad I, Raja RR

Evaluation of diagnostic criteria for ankylosing spondylitis

Author(s): van der Linden S, Valkenburg HA, Cats A

Holter monitoring in ankylosing spondylitis patients during methylprednisolone pulse therapy

Author(s): Nasswetter G, Piñeiro DJ, Garcia Morteo OM, Maldonado Cocco JA, Barreira JC, et al.